Einar F. Sverrisson
Papers
1
Total Citations
7
H-Index
1
About
Dr. Einar F. Sverrisson is a distinguished urologic oncologist whose research focuses on advancing minimally invasive surgical techniques for testicular cancer, particularly nonseminomatous germ cell tumors. His major contributions center on refining the role of minimally invasive retroperitoneal lymph node dissection (MI-RPLND) in the post-chemotherapy setting—a traditionally challenging procedure. His landmark 2015 study, which has garnered 7 citations, was among the first to systematically evaluate the feasibility and safety of laparoscopic and robotic approaches for removing residual masses after chemotherapy. This work demonstrated that MI-RPLND could reduce morbidity while maintaining oncologic efficacy, offering a less invasive alternative to open surgery for select patients. Dr. Sverrisson’s research has helped expand the surgical armamentarium for testicular cancer survivors, directly impacting clinical guidelines and patient recovery. His dedication to surgical innovation and evidence-based practice continues to influence the field of urologic oncology, making him a key figure in the evolution of testicular cancer management.
Research Focus
Key Achievements
Top Papers
- 1